» Articles » PMID: 16474159

Natural Killer Cell Function is Well Preserved in Asymptomatic Human Immunodeficiency Virus Type 2 (HIV-2) Infection but Similar to That of HIV-1 Infection when CD4 T-cell Counts Fall

Overview
Journal J Virol
Date 2006 Feb 14
PMID 16474159
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Natural killer (NK) cells are potent effectors of natural immunity and their activity prevents human immunodeficiency virus type 1 (HIV-1) viral entry and viral replication. We sought to determine whether NK immune responses are associated with different clinical course of HIV-1 and HIV-2 infections. A cross-sectional analysis of NK cell responses was undertaken in 30 HIV-1 and 30 HIV-2 subjects in each of three categories of CD4(+)-T-cell counts (>500, 200 to 500, and <200 cells/microl) and in 50 HIV-uninfected control subjects. Lytic activity and gamma interferon (IFN-gamma) secretion were measured by chromium release and enzyme-linked immunospot assays, respectively. Flow cytometry was used to assess intracellular cytokines and chemokines. Levels of NK cytotoxicity were significantly higher in HIV-2 than in HIV-1 infections in subjects with high CD4(+)-T-cell counts and were similar to that of the healthy controls. In these HIV-2 subjects, cytolytic activity was positively correlated to NK cell count and inversely related to plasma viremia. Levels of intracellular MIP-1beta, RANTES, tumor necrosis factor alpha, and IFN-gamma produced by NK CD56(bright) cells were significantly higher in HIV-2- than HIV-1-infected subjects with high CD4(+)-T-cell counts but fell to similar levels as CD4 counts dropped. The data suggest efficient cytolytic and chemokine-suppressive activity of NK cells early in HIV-2 infection, which is associated with high CD4(+) T-cell counts. Enhancement of these functions may be important in immune-based therapy to control HIV disease.

Citing Articles

Mitochondrial Oxidative Stress Regulates FOXP3+ T-Cell Activity and CD4-Mediated Inflammation in Older Adults with Frailty.

Gill J, Bansal B, Guo K, Huang F, Singh H, Hur J Int J Mol Sci. 2024; 25(11).

PMID: 38892421 PMC: 11173216. DOI: 10.3390/ijms25116235.


Role of Circulating T Follicular Helper Cells and Stem-Like Memory CD4 T Cells in the Pathogenesis of HIV-2 Infection and Disease Progression.

Ponnan S, Vidyavijayan K, Thiruvengadam K, J N, Mathayan M, Murugavel K Front Immunol. 2021; 12:666388.

PMID: 33936106 PMC: 8085399. DOI: 10.3389/fimmu.2021.666388.


Conventional Dendritic Cells and Slan Monocytes During HIV-2 Infection.

Iannetta M, Isnard S, Manuzak J, Guillerme J, Notin M, Bailly K Front Immunol. 2020; 11:1658.

PMID: 32903610 PMC: 7438582. DOI: 10.3389/fimmu.2020.01658.


HIV-2 as a model to identify a functional HIV cure.

Esbjornsson J, Jansson M, Jespersen S, Mansson F, Honge B, Lindman J AIDS Res Ther. 2019; 16(1):24.

PMID: 31484562 PMC: 6727498. DOI: 10.1186/s12981-019-0239-x.


Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection.

Samri A, Charpentier C, Diallo M, Bertine M, Even S, Morin V PLoS Pathog. 2019; 15(5):e1007758.

PMID: 31095640 PMC: 6541300. DOI: 10.1371/journal.ppat.1007758.


References
1.
van der Ende M, Schutten M, Ly T, Gruters R, Osterhaus A . HIV-2 infection in 12 European residents: virus characteristics and disease progression. AIDS. 1996; 10(14):1649-55. DOI: 10.1097/00002030-199612000-00009. View

2.
Carson W, Giri J, Lindemann M, Linett M, Ahdieh M, Paxton R . Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med. 1994; 180(4):1395-403. PMC: 2191697. DOI: 10.1084/jem.180.4.1395. View

3.
Weber K, Meyer D, Grosse V, Stoll M, Schmidt R, Heiken H . Reconstitution of NK cell activity in HIV-1 infected individuals receiving antiretroviral therapy. Immunobiology. 2000; 202(2):172-8. DOI: 10.1016/S0171-2985(00)80063-7. View

4.
Landay A, Mackewicz C, Levy J . An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin Immunol Immunopathol. 1993; 69(1):106-16. DOI: 10.1006/clin.1993.1157. View

5.
Hu P, Hultin L, Hultin P, Hausner M, Hirji K, Jewett A . Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 10(3):331-40. View